Screener
Bio-Rad Laboratories BIO Goodwill
Goodwill at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| ASSETS | March 31, 2026 / (Unaudited) | December 31, 2025 |
|---|---|---|
| Total current assets | 2,942.1 | 2,906.2 |
| Property, plant and equipment, net | 527.5 | 539.9 |
| Operating lease right-of-use assets | 161.9 | 170.0 |
| Goodwill, net | 577.1 | 579.8 |
| Purchased intangibles, net | 166.8 | 174.3 |
| Other investments | 5,311.8 | 6,103.6 |
| Other assets | 102.8 | 102.7 |
| Total assets | $9,790.0 | $10,576.5 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's goodwill?
- Bio-Rad Laboratories (BIO) reported goodwill of $577.1M in Q1 2026.
- How has Bio-Rad Laboratories's goodwill changed year-over-year?
- Bio-Rad Laboratories's goodwill increased by 39.2% year-over-year, from $414.6M to $577.1M.
- What is the long-term trend for Bio-Rad Laboratories's goodwill?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's goodwill has grown at a 14.7% compound annual growth rate (CAGR), from $291.9M to $579.8M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.
Ask your AI about Bio-Rad Laboratories's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude